{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:16:52Z","timestamp":1788279412242,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"crossref","award":["FP01606073"],"award-info":[{"award-number":["FP01606073"]}],"id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12020-019-01855-7","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T17:19:30Z","timestamp":1549646370000},"page":"584-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with huge goitrous Hashimoto\u2019s thyroiditis"],"prefix":"10.1007","volume":"64","author":[{"given":"Azusa","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsushige","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Shiojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaoki","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"issue":"1","key":"1855_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1210\/edrv-2-1-87","volume":"2","author":"PR Larsen","year":"1981","unstructured":"P.R. Larsen, J.E. Silva, M.M. Kaplan, Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2(1), 87\u2013102 (1981)","journal-title":"Endocr. Rev."},{"issue":"4","key":"1855_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/thy.1997.7.655","volume":"7","author":"DL Germain St.","year":"1997","unstructured":"D.L. St. Germain, V.A. Galton, The deiodinase family of selenoproteins. Thyroid 7(4), 655\u2013668 (1997)","journal-title":"Thyroid"},{"issue":"1","key":"1855_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","volume":"23","author":"AC Bianco","year":"2002","unstructured":"A.C. Bianco, D. Salvatore, B. Gereben, M.J. Berry, P.R. Larsen, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23(1), 38\u201389 (2002)","journal-title":"Endocr. Rev."},{"issue":"8","key":"1855_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1089\/thy.2005.15.787","volume":"15","author":"GGJM Kuiper","year":"2005","unstructured":"G.G.J.M. Kuiper, M.H.A. Kester, R.P. Peeters, T.J. Visser, Biochemical mechanisms of thyroid hormone deiodination. Thyroid 15(8), 787\u2013798 (2005)","journal-title":"Thyroid"},{"issue":"4","key":"1855_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1172\/JCI118880","volume":"98","author":"D Salvatore","year":"1996","unstructured":"D. Salvatore, H. Tu, J.W. Harney, P.R. Larsen, Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J. Clin. Invest. 98(4), 962\u2013968 (1996)","journal-title":"J. Clin. Invest."},{"issue":"6","key":"1855_CR6","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/jc.2007-0178","volume":"92","author":"P Laurberg","year":"2007","unstructured":"P. Laurberg, H. Vestergaard, S. Nielsen, S.E. Christensen, T. Seefeldt, K. Helleberg, K.M. Pedersen, Source of circulating 3,5,3\u2019-triiodothyronine in hyperthyroidism estimated after blocking type 1 and type 2 iodothyronine deiodinses. J. Clin. Endocrinol. Metab. 92(6), 2149\u20132156 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1855_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/jc.2002-020921","volume":"88","author":"BW Kim","year":"2003","unstructured":"B.W. Kim, G.H. Daniels, B.J. Harrison, A. Price, J.W. Harney, P.R. Larsen, A.P. Weetman, Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J. Clin. Endocrinol. Metab. 88(2), 594\u2013598 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1855_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/eje.0.1490443","volume":"149","author":"AP Weetman","year":"2003","unstructured":"A.P. Weetman, C.A. Shepherdley, P. Mansell, C.S. Ubhi, T.J. Visser, Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. Eur. J. Endocrinol. 149(5), 443\u2013447 (2003)","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"1855_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1210\/jc.2006-1242","volume":"92","author":"Y Kanou","year":"2007","unstructured":"Y. Kanou, A. Hishinuma, K. Tsunekawa, K. Seki, Y. Mizuno, H. Fujisawa, T. Imai, Y. Miura, T. Nagasaka, C. Yamada, T. Ieiri, M. Murakami, Y. Murata, Thyroglobulin gene mutations producing defective intracellular transport of thyroglobulin are associated with increased type 2 iodothyronine deiodinase activity. J. Clin. Endocrinol. Metab. 92(4), 1451\u20131457 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1855_CR10","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1210\/jc.2007-2237","volume":"93","author":"FS Celi","year":"2008","unstructured":"F.S. Celi, G. Coppotelli, A. Chidakel, M. Kelly, B.A. Brillante, T. Shawker, N. Cherman, P.P. Feuillan, M.T. Collins, The role of type 1 and type 2 5\u2019-deiodinase in the pathophysiology of the 3,5,3\u2019-triiodothyronine toxicosis of McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 93(6), 2383\u20132389 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1855_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1530\/EJE-10-0736","volume":"164","author":"M Ito","year":"2011","unstructured":"M. Ito, N. Toyoda, E. Nomura, Y. Takamura, N. Amino, T. Iwasaka, J. Takamatsu, A. Miyauchi, M. Nishikawa, Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3\u2019-triiodothyronine-predominant Graves\u2019 disease. Eur. J. Endocrinol. 164(1), 95\u2013100 (2011)","journal-title":"Eur. J. Endocrinol."},{"key":"1855_CR12","unstructured":"N. Toyoda, E. Nomura, M. Ito, A. Harada, K. Nishimura, C. Ukita, T. Iwasaka, S. Kubota, A. Miyauchi, M. Nishikawa, Type 2 iodothyronine deiodinase activity is highly expressed in the large goiter with Hashimoto\u2019s thyroiditis. Program of the 14th International Congress of Endocrinology. The Japan Endocrine Society (Kyoto, Japan, 2010), p S478, (Abstract P4-16-2)"},{"issue":"9","key":"1855_CR13","first-page":"3257","volume":"81","author":"Y Murakami","year":"1996","unstructured":"Y. Murakami, J. Takamatsu, S. Sakane, K. Kuma, N. Ohsawa, Changes in thyroid volume in response to radioactive iodine for Graves\u2019 hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J. Clin. Endocrinol. Metab. 81(9), 3257\u20133260 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1855_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1210\/jcem-28-2-305","volume":"28","author":"D Bellabarba","year":"1968","unstructured":"D. Bellabarba, R.E. Peterson, K. Sterling, An improved method for chromatography of iodothyronines. J. Clin. Endocrinol. Metab. 28(2), 305\u2013307 (1968)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1855_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1530\/EJE-11-1029","volume":"167","author":"M Ito","year":"2012","unstructured":"M. Ito, A. Miyauchi, S. Morita, T. Kudo, E. Nishihara, M. Kihara, Y. Takamura, Y. Ito, K. Kobayashi, A. Miya, S. Kubota, N. Amino, TSH-suppresive dose of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur. J. Endocrinol. 167(3), 373\u2013378 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"1855_CR16","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1210\/mend.14.11.0558","volume":"14","author":"B Gereben","year":"2000","unstructured":"B. Gereben, C. Goncalves, J.W. Harney, P.R. Larsen, A.C. Bianco, Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol. Endocrinol. 14(11), 1697\u20131708 (2000)","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"1855_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1089\/105072501753210957","volume":"11","author":"Y Imai","year":"2001","unstructured":"Y. Imai, N. Toyoda, A. Maeda, T. Kadobayashi, F. Wang, K. Kuma, M. Nishikawa, T. Iwasaka, Type 2 iodothyronine deiodinase expression is upregulated by the protein kinase A-dependent pathway and is downregulated by the protein kinase C-dependent pathway in cultured human thyroid cells. Thyroid 11(10), 899\u2013907 (2001)","journal-title":"Thyroid"},{"issue":"5","key":"1855_CR18","first-page":"1476","volume":"81","author":"DL Germain","year":"1988","unstructured":"D.L. Germain, Dual mechanisms of regulation of type I iodothyronine 5\u2019-deiodinase in the rat kidney, liver, and thyroid gland. Implic. Treat. hyperthyroidism Radiogr. Contrast Agents J. Clin. Invest. 81(5), 1476\u20131484 (1988)","journal-title":"Implic. Treat. hyperthyroidism Radiogr. Contrast Agents J. Clin. Invest."},{"key":"1855_CR19","unstructured":"A.P. Weetman, in Werner & Ingbar\u2019s The Thyroid, ed. by L.E. Braverman, D.S. Cooper, D.S. (eds.) 10th edn. (Lippincott Williams & Willkins, Philadelphia, 2013), pp. 525\u2013535"},{"issue":"9","key":"1855_CR20","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1172\/JCI25083","volume":"115","author":"AL Maia","year":"2005","unstructured":"A.L. Maia, B.W. Kim, S.A. Huang, J.W. Harney, P.R. Larsen, Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J. Clin. Invest. 115(9), 2524\u20132533 (2005)","journal-title":"J. Clin. Invest."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01855-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01855-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01855-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T19:26:09Z","timestamp":1581103569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01855-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1855"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01855-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"10 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee at Kuma Hospital, and all patients gave informed consent for their materials to be used and for their data to be published. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}